Interacting Drugs |
Efavirenz vs CYP3A4 Substrates |
Security Level |
|
Mechanism |
CYP3A4 Substrates: CYP3A4 Inducers (Strong) may increase the metabolism of CYP3A4 Substrates. |
Management |
Monitor therapy |
Efavirenz vs CYP3A4 Substrates
Post Review about Efavirenz vs CYP3A4 Substrates Click here to cancel reply.
Other Interactions of Efavirenz
Other Interactions of CYP3A4 Substrates
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.